Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $70,726 - $78,544
-687 Reduced 22.25%
2,400 $247,000
Q2 2023

Aug 09, 2023

SELL
$108.61 - $118.38 $43,987 - $47,943
-405 Reduced 11.6%
3,087 $356,000
Q1 2023

May 10, 2023

SELL
$102.94 - $114.86 $84,307 - $94,070
-819 Reduced 19.0%
3,492 $371,000
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $20,723 - $26,570
237 Added 5.82%
4,311 $478,000
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $45,477 - $51,088
538 Added 15.21%
4,074 $351,000
Q2 2022

Aug 08, 2022

BUY
$83.49 - $94.64 $47,088 - $53,376
564 Added 18.98%
3,536 $322,000
Q1 2022

May 11, 2022

BUY
$73.51 - $82.4 $2,278 - $2,554
31 Added 1.05%
2,972 $244,000
Q4 2021

Feb 11, 2022

SELL
$72.28 - $90.54 $47,126 - $59,032
-652 Reduced 18.15%
2,941 $225,000
Q3 2021

Nov 12, 2021

SELL
$71.68 - $78.83 $148,234 - $163,020
-2,068 Reduced 36.53%
3,593 $270,000
Q2 2021

Aug 10, 2021

BUY
$70.31 - $77.77 $66,232 - $73,259
942 Added 19.96%
5,661 $440,000
Q1 2021

May 14, 2021

SELL
$68.86 - $81.11 $483,259 - $569,229
-7,018 Reduced 59.79%
4,719 $364,000
Q4 2020

Feb 12, 2021

BUY
$71.77 - $79.65 $348,443 - $386,700
4,855 Added 70.55%
11,737 $960,000
Q3 2020

Oct 30, 2020

SELL
$73.18 - $82.95 $14,562 - $16,507
-199 Reduced 2.81%
6,882 $571,000
Q2 2020

Aug 13, 2020

BUY
$70.42 - $80.13 $498,644 - $567,400
7,081 New
7,081 $548,000
Q1 2020

May 15, 2020

SELL
$63.36 - $87.82 $1.25 Million - $1.73 Million
-19,711 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$77.58 - $87.54 $1.53 Million - $1.73 Million
19,711 New
19,711 $1.79 Million
Q2 2019

Aug 14, 2019

SELL
$69.84 - $81.59 $1.85 Million - $2.16 Million
-26,463 Closed
0 $0
Q1 2019

May 10, 2019

SELL
$69.58 - $79.36 $925,831 - $1.06 Million
-13,306 Reduced 33.46%
26,463 $2.2 Million
Q4 2018

Feb 14, 2019

BUY
$65.24 - $75.71 $2.59 Million - $3.01 Million
39,769 New
39,769 $3.04 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $261B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Rock Creek Group, LP Portfolio

Follow Rock Creek Group, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rock Creek Group, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rock Creek Group, LP with notifications on news.